Objective To determine ii phospholipase A(2) (PLA(2)) type II and type
IV mRNA expression and protein are altered in chronic pancreatitis. S
ummary Background Data PLA(2)s have an important regulatory function i
n several signaling pathways, especially in inflammation. In this stud
y, we examined the expression of three PLA(2) isoforms (type I, type I
I, and type IV) in chronic pancreatitis. Methods The distribution of P
LA(2) was studied in 15 pancreas samples obtained from patients with c
hronic pancreatitis using immunohistochemical, Northern blot, and in s
itu hybridization techniques. Normal pancreas obtained from healthy or
gan donors served as control. Results Northern blot analysis revealed
enhanced mRNA levels of PLA(2) type II (5.7-fold) and type IV (5.1-fol
d) in chronic pancreatitis (p < 0.01) versus normal pancreas. In norma
l pancreas, intense PLA(2) type I immunostaining was present in acinar
cells, whereas PLA(2) type II immunostaining was visible only in some
acinar cells. In chronic pancreatitis, PLA(2) type II immunostaining
was present more frequently and with higher intensity in acinar cells.
Furthermore, PLA(2) type II immunoreactivity was more abundant in met
aplastic ductal cells in the chronic pancreatitis samples. By in situ
hybridization, areas with ductal metaplasia in chronic pancreatitis ex
hibited intense PLA(2) type IV mRNA signals. All chronic pancreatitis
tissues with concomitantly increased mRNA expression for PLA(2) type I
I and type IV exhibited a higher degree of degeneration, ductal metapl
asia, and fibrosis. Conclusions Upregulation of PLA(2) types II and IV
in areas with more histologic damage suggests that these PLA(2) isofo
rms might contribute to the morphologic changes that occur in chronic
pancreatitis.